Exsilio Therapeutics

NEWS

Pictured: An hourglass connected by strands of DNA

Business

Exsilio Launches With $82M to Tackle Gene Therapy Challenges in Novel Approach

Exsilio Therapeutics emerged from stealth on Tuesday with a platform that leverages mRNA technology to develop redosable genomic medicines for a range of complex diseases.

June 25, 2024

4 min read

Ben Hargreaves

IN THE PRESS

Genetown

Exsilio Therapeutics Launches with $82 Million Series A Financing to Develop Redosable Genomic Medicines for A Broad Range of Diseases

June 25, 2024

3 min read

JOBS